TP53 and nonpapillary renal cell carcinoma: Subtype R2 has the highest expression of genes involved in cell cycle, p53 signaling pathway and ECM-receptor interaction and the lowest expression of genes involved in multiple metabolism pathways (Figure 6D), which may promote aggressive behavior of ccRCC and account for poor prognosis of R2.